abstract |
FIELD: biotechnology. n SUBSTANCE: invention relates to the field of biotechnology, in particular to a method for the treatment of psoriatic arthritis in humans, including the stage of administering to a person at least one dose of a neutralizing antibody that binds to human IL-17A and human IL-17F. n EFFECT: invention provides for treatment of arthritis with improved indicators of clinical effects. n 17 cl, 16 dwg, 1 tbl, 3 ex |